There are nearly 30 million people in the United States and over 300 million worldwide who have been diagnosed with dry eye. Most have learned to live with eye discomfort and have become dependent on drops or other treatment methods that only offer temporary relief. This has been due to a lack of understanding that the root cause of most dry eye is now known to be a chronic and progressive condition, Meibomian Gland Dysfunction or MGD. MGD affects 86% of all those with Dry Eye and it’s treatable.
Treating MGD with LipiFlow®
While there are multiple choices available for treating MGD, LipiFlow is the only FDA-cleared device for removing gland blockages and restoring gland function. Through advances in the application of Vectored Thermal Pulsation (VTPTM) technology, the LipiFlow treatment utilizes a patented algorithm of heat applied to the inner eyelids and massage to remove the obstructions in your meibomian glands.
